APP and Cognitive impairment: Various transgenic models for AD like APP/PS1 mice have been reported to exhibit cognitive defects reflected by impaired learning and memory (87, 88, 117), which is why they have served as a very useful model for studying AD pathology as well as developing anti-AD therapeutics (118, 119, 120, 121, 122).